Nuvoco Vistas Corporation Limited has informed the Exchange about Schedule of meet
United Drilling Tools Limited has informed the Exchange regarding Earning Call Transcript.
KEI Industries Limited has informed the Exchange about Copy of Newspaper Publication
Bliss GVS Pharma Limited has informed the Exchange regarding Intimation of GMP Compliance Certificate from TGA.
Hindalco Industries has allotted 1192 equity shares under ESOS on 14 February 2022
Smartlink Holdings Limited has informed the Exchange regarding Extract of Minutes/Proceedings of Postal Ballot.
Welspun Enterprises has allotted 769000 equity shares under ESOP on 12 February 2022 Consequently the equity share capital has increased to 149783056 aggregating Rs 14978 crore
Parenteral Drugs (India) Limited with respect to announcement dated 02-Feb-2022, regarding appointment of Director and Company secretary in the Board meeting held on February 02, 2022. On basis of above the Company is required to clarify following: 1. Date of appointment/cessation (as applicable) & term of appointment 2. Brief profile (in case of appointment) 3. Whether intimated in 24hrs 4. Affirmationﾠthat the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authority.? The response of the Company is awaited.
Total Transport Systems Limited with respect to announcement dated 11-Feb-2022, regarding? Investment in 60% of paid up share capital of R N FREIGHT FORWARDERS PRIVATE LIMITED. On basis of above the Company was required to clarify following: 1. Name of the target entity, details in brief such as size, turnover etc; 2. Brief background about the entity acquired in terms of products/line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in brief). The response of the Company is attached.
The Board of Nureca at its meeting held on 12 February 2022 has approved the appointment of Sushil Kumar Bhardwaj DIN 09468448 as an Additional Director Whole-time Director of the Company designated as Director – Compliance for a period of three years with effect from 12 February 2022
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
